Literature DB >> 15090665

Changing trends in US mesothelioma incidence.

H Weill1, J M Hughes, A M Churg.   

Abstract

AIMS: To report the temporal pattern and change in trend of mesothelioma incidence in the United States since 1973.
METHODS: The Surveillance, Epidemiology, and End Results (SEER) programme of the National Cancer Institute has since 1973 provided annual age adjusted incidence for mesothelioma in representative cancer registries dispersed throughout the USA. SEER data are analysed to describe the trend of male mesothelioma incidence in the USA.
RESULTS: The US male mesothelioma incidence data indicate that after two decades of increasing incidence, a likely decline has been observed since the early 1990s, when a highly significant change in the upward course occurred.
CONCLUSIONS: Increasing male mesothelioma incidence for many years was undoubtedly the result of exposure to asbestos. The high mesothelioma risk was prominently influenced by exposure to amphibole asbestos (crocidolite and amosite), which reached its peak usage in the 1960s and thereafter declined. A differing pattern in some other countries (continuing rise in incidence) may be related to their greater and later amphibole use, particularly crocidolite. The known latency period for the development of this tumour provides biological plausibility for the recent decline in mesothelioma incidence in the USA. This favourable finding is contrary to a widespread fear that asbestos related health effects will show an inevitable increase in coming years, or even decades.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090665      PMCID: PMC1740785          DOI: 10.1136/oem.2003.010165

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  15 in total

1.  Mesothelioma incidence seems to have leveled off in Sweden.

Authors:  Kari Hemminki; Xinjun Li
Journal:  Int J Cancer       Date:  2003-01-01       Impact factor: 7.396

2.  Predictions of mortality from mesothelioma.

Authors:  G Berry; A W Musk; N H De Klerk; A Johnson; D H Yates
Journal:  Occup Environ Med       Date:  2003-06       Impact factor: 4.402

3.  Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients.

Authors:  Scott A J Kerrigan; Rael T Turnnir; Philip B Clement; Robert H Young; Andrew Churg
Journal:  Cancer       Date:  2002-01-15       Impact factor: 6.860

4.  Future trends in mortality of French men from mesothelioma.

Authors:  A Banaei; B Auvert; M Goldberg; A Gueguen; D Luce; S Goldberg
Journal:  Occup Environ Med       Date:  2000-07       Impact factor: 4.402

5.  Malignant mesothelioma in Australia, 1945-2000.

Authors:  James Leigh; Patricia Davidson; Leigh Hendrie; Dale Berry
Journal:  Am J Ind Med       Date:  2002-03       Impact factor: 2.214

6.  The rise and fall in incidence of malignant mesothelioma from a British Naval Dockyard, 1979-1999.

Authors:  A K Hilliard; J K Lovett; C R McGavin
Journal:  Occup Med (Lond)       Date:  2003-05       Impact factor: 1.611

7.  Update of predictions of mortality from pleural mesothelioma in the Netherlands.

Authors:  O Segura; A Burdorf; C Looman
Journal:  Occup Environ Med       Date:  2003-01       Impact factor: 4.402

Review 8.  Latent period for malignant mesothelioma of occupational origin.

Authors:  B P Lanphear; C R Buncher
Journal:  J Occup Med       Date:  1992-07

9.  Recent trends in mesothelioma incidence in the United States.

Authors:  R Spirtas; G W Beebe; R R Connelly; W E Wright; J M Peters; R P Sherwin; B E Henderson; A Stark; B M Kovasznay; J N Davies
Journal:  Am J Ind Med       Date:  1986       Impact factor: 2.214

10.  The European mesothelioma epidemic.

Authors:  J Peto; A Decarli; C La Vecchia; F Levi; E Negri
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

View more
  30 in total

1.  Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.

Authors:  Vanya Delgermaa; Ken Takahashi; Eun-Kee Park; Giang Vinh Le; Toshiyuki Hara; Tom Sorahan
Journal:  Bull World Health Organ       Date:  2011-06-13       Impact factor: 9.408

Review 2.  Cellular and molecular parameters of mesothelioma.

Authors:  Maria E Ramos-Nino; Joseph R Testa; Deborah A Altomare; Harvey I Pass; Michele Carbone; Maurizio Bocchetta; Brooke T Mossman
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

3.  Computerized segmentation and measurement of malignant pleural mesothelioma.

Authors:  William F Sensakovic; Samuel G Armato; Christopher Straus; Rachael Y Roberts; Philip Caligiuri; Adam Starkey; Hedy L Kindler
Journal:  Med Phys       Date:  2011-01       Impact factor: 4.071

4.  Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma.

Authors:  Erick Riquelme; Milind B Suraokar; Jaime Rodriguez; Barbara Mino; Heather Y Lin; David C Rice; Anne Tsao; Ignacio I Wistuba
Journal:  J Thorac Oncol       Date:  2014-07       Impact factor: 15.609

5.  Optimization of response classification criteria for patients with malignant pleural mesothelioma.

Authors:  Zacariah E Labby; Samuel G Armato; Hedy L Kindler; James J Dignam; Arman Hasani; Anna K Nowak
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

6.  Malignant peritoneal mesothelioma.

Authors:  Stine Munkholm-Larsen; Christopher Q Cao; Tristan D Yan
Journal:  World J Gastrointest Surg       Date:  2009-11-30

7.  Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.

Authors:  Michael K Felten; Khaled Khatab; Lars Knoll; Thomas Schettgen; Hendrik Müller-Berndorff; Thomas Kraus
Journal:  Int Arch Occup Environ Health       Date:  2013-02-20       Impact factor: 3.015

Review 8.  MET as a target for treatment of chest tumors.

Authors:  Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
Journal:  Lung Cancer       Date:  2008-07-30       Impact factor: 5.705

9.  DNA methylation profile of 28 potential marker loci in malignant mesothelioma.

Authors:  Jeffrey A Tsou; Janice S Galler; Anil Wali; Wei Ye; Kimberly D Siegmund; Susan Groshen; Peter W Laird; Sally Turla; Michael N Koss; Harvey I Pass; Ite A Laird-Offringa
Journal:  Lung Cancer       Date:  2007-07-30       Impact factor: 5.705

10.  Projected mesothelioma incidence in men in New South Wales.

Authors:  Mark Clements; Geoffrey Berry; Jill Shi; Sandra Ware; Deborah Yates; Anthony Johnson
Journal:  Occup Environ Med       Date:  2007-04-20       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.